Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. (600436 CH)
Watchlist
81
Analysis
Health Care
•
China
Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. manufactures and markets Chinese traditional medicines, including Pientzehuang, Pientzehuang capsules, Pientzehuang lozenge, cough syrup, and other related products.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
China Traditional Chinese Medicine
•
06 Nov 2023 09:11
China Healthcare–A Pair Trade Between China TCM (570.HK) And Pientzehuang Pharmaceutical (600436.CH)
TCM granules business recovery makes us optimistic about China TCM's 2023 results, but Pientzehuang's performance will remain under pressure. So,...
Xinyao (Criss) Wang
Follow
401 Views
Share
bullish
•
Thematic (Sector/Industry)
•
16 Jul 2023 09:59
China Healthcare Weekly (Jul.14)-TCM Demand Switch, 8% Benchmark Growth Rate, GLP-1 Change Game Rule
8% could be a benchmark growth rate for future healthcare industry. People's TCM demand switch will lead to changes in TCM company's performance....
Xinyao (Criss) Wang
Follow
299 Views
Share
bullish
•
Thematic (Sector/Industry)
•
13 Jun 2023 08:55
The Cyclicality of China Healthcare - Policy Environment, the Industry, and Investment Opportunities
Without industry beta, China healthcare companies still have opportunity to achieve countercyclical breakthrough.Investors need to be in line with...
Xinyao (Criss) Wang
Follow
295 Views
Share
bullish
•
Thematic (Sector/Industry)
•
10 May 2023 08:55
Valuation System with Chinese Characteristics – the Correct Interpretation and Its Deep Meaning
Many investors do not have a deep understanding of the "valuation system with Chinese characteristics". It is necessary to provide some...
Xinyao (Criss) Wang
Follow
369 Views
Share
bullish
•
Lifetech Scientific
•
07 May 2023 09:20
China Healthcare Weekly (May.5)- 2nd Wave of COVID, Valuation Logic of China's Core Assets, Lifetech
It's time to talk about the 2nd wave of COVID in China.Investors need to understand deep meaning/valuation logic of China's core assets so as not...
Xinyao (Criss) Wang
Follow
271 Views
Share
Previous
1
2
3
4
5
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.31.2
x